Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Jelic, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 52 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jelic, S; Babovic, N; Stamatovic, L; Kreacic, M; Matkovic, S; Popov, I
      Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study

      MEDICAL ONCOLOGY
    2. Stahel, R; Purkalne, G; Herrstedt, J; Jelic, S; Fervers, B; Kloke, O; Mellstedt, H; Pavlidis, N; Jost, L
      ESMO Minimum Clinical Recommendations - the beginning of a process

      ANNALS OF ONCOLOGY
    3. Jassem, J; Pienkowski, T; Pluzanska, A; Jelic, S; Gorbunova, V; Mrsic-Krmpotic, Z; Berzins, J; Nagykalnai, T; Wigler, N; Renard, J; Munier, S; Weil, C
      Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial

      JOURNAL OF CLINICAL ONCOLOGY
    4. Popov, I; Jelic, S; Radosavljevic, D; Nikolic-Tomasevic, Z
      Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: A phase-II study

      EUROPEAN UROLOGY
    5. Jelic, S; Mitrovic, L; Radosavljevic, D; Elezar, E; Babovic, N; Kovcin, V; Tomasevic, Z; Kovacevic, S; Gavrilovic, D; Radulovic, S
      Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

      LUNG CANCER
    6. Nikolic-Tomasevic, Z; Jelic, S; Popov, I; Radosavljevic, D; Mitrovic, L
      Tumor 'flare' hypercalcemia - An additional indication for bisphosphonates?

      ONCOLOGY
    7. Konjevic, G; Jovic, V; Radulovic, S; Jelic, S; Dzodic, R; Spuzic, I
      Therapeutic implications of the kinetics of immunomodulation during singleor combined treatment of melanoma patients with dacarbazine and interferon-alpha

      NEOPLASMA
    8. Nikolic-Tomasevic, Z; Jelic, S; Popov, I; Radosavljevic, D
      Irinotecan as second-line treatment in metastatic colorectal cancer: Dilemmas regarding patient selection and toxicity prediction

      JOURNAL OF CHEMOTHERAPY
    9. Popov, I; Jelic, S; Radulovic, S; Radosavljevic, D; Nikolic-Tomasevic, Z
      Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial

      ANNALS OF ONCOLOGY
    10. Colakovic, S; Lukic, V; Mitrovic, L; Jelic, S; Susnjar, S; Marinkovic, J
      Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    11. Babovic, N; Jelic, S; Jovanovic, V
      Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy?

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    12. Susnjar, S; Vasovic, S; Neskovic-Konstantinovic, Z; Stamatovic, L; Lukic, V; Colakovic, S; Mitrovic, L; Jelic, S; Radulovic, S
      Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study

      TUMORI
    13. Jelic, S; Filipovic-Ljeskovic, I
      Positive serology for Lyme disease Borrelias in primary cutaneous B-cell lymphoma: A study in 22 patients; Is it a fortuitous finding?

      HEMATOLOGICAL ONCOLOGY
    14. Milosevic, D; Marinkovic, M; Colovic, M; Jelic, S
      The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients

      PANMINERVA MEDICA
    15. Jelic, S; Milanovic, N; Tomasevic, Z; Matkovic, S; Gavrilovic, D
      Comparison of two non-anthracycline-containing regimens for elderly patients with diffuse large-cell non Hodgkin's lymphoma - possible pitfalls in results reporting and interpretation

      NEOPLASMA
    16. Popov, I; Jelic, S; Radosavljevic, D; Nikolic-Tomasevic, Z
      The role of stable disease in objective response assessment and its impacton survival in advance colorectal cancer: Is "stable disease" a homogenousresponse category?

      NEOPLASMA
    17. TOMASEVICNIKOLIC Z; JELIC S; POPOV I; RADOSAVLJEVIC D; MITROVIC L; TOMASEVIC Z
      TUMOR-INDUCED HYPERCALCEMIA IN METASTATIC BREAST-CANCER - TREATMENT AND POSSIBLE PREDICTIVE FACTORS

      Annals of oncology
    18. POPOV I; JELIC S; RADOSAVLJEVIC D; NIKOLICTOMASEVIC Z
      THE ROLE OF STABLE DISEASE IN OBJECTIVE RESPONSE ASSESSMENT AND ITS IMPACT ON SURVIVAL IN ADVANCED COLORECTAL-CANCER

      Annals of oncology
    19. RADOSAVLJEVIC D; JELIC S; RADULOVIC S; POPOV I; NIKOLICTOMASEVIC Z; GAVRILOVIC D
      DISEASE-RELATED SYMPTOMS DURING CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY FOR ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)

      Annals of oncology
    20. TOMASEVIC Z; JELIC S; NIKOLICTOMASEVIC Z; MILANOVIC N; MATKOVIC S
      PROGNOSTIC-SIGNIFICANCE AND QUALITATIVE-ANALYSIS OF CIRCULATING IMMUNE-COMPLEXES IN HODGKINS-DISEASE

      Annals of oncology
    21. JELIC S; FILIPOVICLJESKOVIC I; NIKOLIC L; MATKOVIC S; MANOJLOVIC N
      PARVOVIRUS B-19 INFECTION IN PATIENTS UNDERGOING CHEMOTHERAPY - A POSSIBLE CAUSE OF UNEXPECTED ANEMIA

      Annals of oncology
    22. Babovic, N; Jelic, S; Milanovic, N; Matkovic, S
      Pilot study of daily ifosfamide 1 g/m(2) until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcoma

      TUMORI
    23. JELIC S; DIMKOVIC S; KANDIC D; KOSTIC N; BOJKOVIC G; CAPAREVIC Z
      TIGHT BLOOD-PRESSURE CONTROL RETARDS PROGRESSION OF NEPHROPATHY IN TYPE-2 DIABETICS

      Diabetologia
    24. JELIC S; MILANOVIC N; TOMASEVIC Z; MATKOVIC S
      COMPARISON OF 2 NON-ANTHRACYCLINE-CONTAINING REGIMENS FOR ELDERLY PATIENTS WITH DIFFUSE LARGE-CELL NHL - POSSIBLE PITFALLS IN RESULTS REPORTING AND INTERPRETATION

      British Journal of Haematology
    25. JELIC S; NIKOLICTOMASEVIC Z; KOVCIN V; MILANOVIC N; TOMASEVIC Z; JOVANOVIC V; VLAJIC M
      A 2-STEP REEVALUATION OF HIGH-DOSE AMSACRIN FOR ADVANCED-CARCINOMA OFTHE UPPER AERODIGESTIVE TRACT - A PILOT PHASE-II STUDY

      Journal of chemotherapy
    26. JELIC S; KOVCIN V; MILANOVIC N; BABOVIC N; KREACIC M; RISTOVIC Z; VLAJIC M; FILIPOVICLJESKOVIC I
      RANDOMIZED STUDY OF HIGH-DOSE EPIRUBICIN VERSUS HIGH-DOSE EPIRUBICIN-CISPLATIN CHEMOTHERAPY FOR ADVANCED SOFT-TISSUE SARCOMA

      European journal of cancer
    27. RADOSAVLJEVIC D; JELIC S; RADULOVIC S; GAVRILOVIC D; POPOV I
      SYMPTOM DISTRESS IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER TREATED WITH CHEMOTHERAPY

      European journal of cancer
    28. JELIC S; KOVCIN V; MILANOVIC N; KREACIC M; PENDJER I; JOVANOVIC V; RISTOVIC Z; OPRIC M; MITROVIC L
      RANDOMIZED STUDY OF ZORUBICIN VERSUS ZORUBICIN-CISPLATIN IN UNDIFFERENTIATED CARCINOMA OF THE NASOPHARYNX (UCNT)

      Annals of oncology
    29. FILIPOVICLJESKOVIC I; JELIC S
      METASTATIC MALIGNANT-MELANOMA AND DISORDER OF HEMOSTASIS

      Thrombosis and haemostasis
    30. JELIC S; FRIM O; GLIGORIJEVIC G; GAVRILOVIC D; MANOJLOVIC N; JOVANOVIC V; OPRIC M
      A CONTROVERSIAL ISSUE - COULD A WATCH-AND-WAIT POLICY FOR PATIENTS WITH NON-HODGKINS-LYMPHOMA CLINICAL STAGE-I OR IE WITH NO LYMPHOMA LEFT FOLLOWING DIAGNOSTIC SURGERY BE JUSTIFIED - RESULTS OF A SINGLE-CENTERSTUDY

      Hematological oncology
    31. SOBICSARANOVIC D; PAVLOVIC S; SUSNJAR S; NESKOVICKONSTANTINOVIC Z; JELIC S
      ASSESSMENT OF EARLY EPIRUBICIN CARDIOTOXICITY IN WOMEN WITH BREAST-CANCER

      Anticancer research
    32. POPOV I; JELIC S; RADOSAVLJEVIC D; NIKOLICTOMASEVIC Z
      ANDROGEN LEVEL VARIATIONS, CLINICAL-RESPONSE TO LHRH, AGONISTS AND CHANGES IN THE QUALITY OF THE SUBSCALES IN METASTATIC PROSTATE-CANCER SPECULATIONS ABOUT POSSIBLE ROLE SF THE MONOAMINE SYSTEM

      Neoplasma
    33. JELIC S; JOVANOVIC V; MILANOVIC N; MARINKOVIC M; KOVCIN V; MILOSEVIC D; VLAJIC M
      RICHTER SYNDROME WITH EMPHASIS ON LARGE-CELL NON-HODGKIN-LYMPHOMA IN PREVIOUSLY UNRECOGNIZED SUBCLINICAL CHRONIC LYMPHOCYTIC-LEUKEMIA

      Neoplasma
    34. KOSTIC N; KOCIJANCIC M; SIMIC D; CAPAREVIC Z; JELIC S; BOJKOVIC G
      CIRCADIAN BLOOD-PRESSURE, CORTISOL AND PROLACTIN IN DIABETIC AUTONOMIC NEUROPATHY

      Diabetologia
    35. JELIC S; DIMKOVIC S; KOCIJANCIC M; KOSTIC N; BOJKOVIC G; CAPAREVIC Z; DILIGENSKI V
      PRESENCE OF NEPHROPATHY INFLUENCES THE CHOICE OF ANTI-HYPERTENSIVES IN INSULIN-DEPENDENT DIABETES

      Diabetologia
    36. CAPAREVIC Z; SIMIC D; JELIC S; KOSTIC N; DILIGENSKI V; BOJKOVIC G
      DYSLIPIDEMIA IN NONDIABETIC SUBJECTS FROM FAMILIES WITH TYPE-2 DIABETES

      Diabetologia
    37. DILIGENSKI V; CAPAREVIC Z; KOSTIC N; JELIC S; BOJKOVIC G
      PANIC DISORDER AND DEPRESSION IN INSULIN-DEPENDENT DIABETES-MELLITUS

      Diabetologia
    38. JELIC S; MITROVIC L; KOVCIN V; NIKOLICTOMASEVIC Z; RADULOVIC S; TOMASEVIC Z; POPOV I
      MODULATION OF CISPLATIN ANTITUMOR-ACTIVITY BY SHORT INFUSIONAL HIGH-DOSE CYTOSINE-ARABINOSIDE IN ADVANCED PRETREATED HEAD AND NECK-CARCINOMA - A PHASE-II STUDY

      Journal of chemotherapy
    39. MILOSEVIC D; MARINKOVIC M; JELIC S; COLOVIC M; SPUZIC I
      B-CELLS NUMBER AND THEIR ACTIVITY IN PATIENTS UNDER THERAPY FOR LEUKEMIA AND LYMPHOMA

      Journal of experimental & clinical cancer research
    40. POPOV I; JELIC S; RADULOVIC S; TOMASEVIC Z
      PILOT-STUDY OF ENHANCEMENT OF CISPLATIN ACTIVITY BY HIGH-DOSE CYTARABINE IN ADVANCED GASTRIC AND COLORECTAL (G3 G4) CANCER/

      Neoplasma
    41. JELIC S; TOMASEVIC Z; KREACIC M; KOVCIN V; RADOSAVLJEVIC D; VLAJIC M
      PILOT-STUDY OF HIGH-DOSE ZORUBICIN IN ADV ANCED SOFT-TISSUE SARCOMA IN ADULTS

      Bulletin du cancer
    42. JANKOVIC L; JELIC S; FILIPOVICLJESKOVIC I; RISTOVIC Z
      SALIVARY IMMUNOGLOBULINS IN CANCER-PATIENTS WITH CHEMOTHERAPY-RELATEDORAL-MUCOSA DAMAGE

      European journal of cancer. Part B, Oral oncology
    43. KOVCIN V; JELIC S; MITROVIC L; RADULOVIC S; TOMASEVIC Z; MILANOVIC N; BABOVIC N; RISTOVIC Z
      COMPARISON OF EFFICACY 2 DIFFERENT DOSE DTIC-BASED CHEMOTHERAPY REGIMENS AND 2 NON-DTIC BASED REGIMENS IN THE TREATMENT OF METASTATIC MALIGNANT-MELANOMA - STUDY IN 159 PATIENTS

      European journal of cancer
    44. RISTOVIC Z; JELIC S; KOVCIN V; VUCKOVIC S; RIBARIC B; VULETICMITROVIC L
      ADVANTAGES OF THE COMPUTER-PROGRAM HEM IN FOLLOWING, PROCESSING AND ANALIZING DATA OF CHEMOTHERAPY TRIALS

      European journal of cancer
    45. JELIC S; MITROVIC L; RADOSAVLIJEVIC D; ELEZAR E; KOVCIN V; RISTOVIC Z; KOVAEVIC S; RADULOVIC S
      CISPLATIN 120 MG M(2) VS CARBOPLATIN 500 MG/M(2) IN COMBINATION WITH MITOMYCIN-C AND VINDESIN - A RANDOMIZED PHASE-III STUDY IN 164 PATIENTS WITH STAGE-IIIB AND STAGE-IV SQUAMOUS-CELL BRONHOGENIC CARCINOMA/

      European journal of cancer
    46. REDULOVIC S; JELIC S; RISTOVIC Z; KOCIC D
      (LACK OF) CORRELATION BETWEEN CARBOPLATIN (CBDCA) DOSE AND TREATMENT OUTCOME IN SQUAMOUS-CELL BRONCHOGENIC-CARCINOMA (NSCLC)

      European journal of cancer
    47. JELIC S; RADULOVIC S; NESKOVICKONSTANTINOVIC Z; KREACIC M; RISTOVIC Z; BOSNJAK S; MILANOVIC N; VULETIC L
      CARDIOPROTECTION WITH ICRF-187 (CARDIOXANE) IN PATIENTS WITH ADVANCEDBREAST-CANCER HAVING CARDIAC RISK-FACTORS FOR DOXORUBICIN CARDIOTOXICITY, TREATED WITH THE FDC REGIMEN

      Supportive care in cancer
    48. KOLARIC K; BRADAMANTE V; CERVEK J; CIESLINSKA A; CISARZFILIPCAK E; DENISOV LE; DONAT D; DROSIK K; GERSHANOVIC M; HUDZIEC P; JELIC S; JURGA L; KALASIEWICZ M; KOWGIRD L; KOZACKA M; LICHINITZER M; MACHALSKI M; MECHL Z; ODINTSOV S; PAWLICKI M; RUBACH D; ROTH A; STABUC B; TOMCZAK J; UTRACKA B; ZBORZIL J; ROGAN J
      A PHASE-II TRIAL OF CARDIOPROTECTION WITH CARDIOXANE (ICRF-187) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE

      Oncology
    49. KOVCIN V; JELIC S; BABOVIC N; TOMASEVIC Z
      A PILOT-STUDY TO ASSESS THE EFFICACY OF SALMON-CALCITONIN IN THE RELIEF OF NEUROPATHIC PAIN CAUSED BY EXTRASKELETAL METASTASES

      Supportive care in cancer
    50. JELIC S; KOVCIN V; JOVANOVIC V; OPRIC M; MILANOVIC N
      PRIMARY GASTRIC NON-HODGKINS-LYMPHOMA LOCALIZED TO THE GASTRIC WALL -NO ADJUVANT TREATMENT FOLLOWING RADICAL SURGERY

      Oncology
    51. MILANOVIC N; JELIC S; JOVANOVIC V; KOVCIN V; OPRIC M; MARINKOVIC M
      NON-IPSID SMALL-INTESTINAL LYMPHOMA - EVIDENCE FOR DISSEMINATED DISEASE AT PRESENTATION

      Neoplasma
    52. KOSTIC N; NOVAKOVIC R; JELIC S; POPOVIC S
      RESPONSE OF PANCREATIC-POLYPEPTIDE TO A PROTEIN-RICH MEAL IN DIABETICAUTONOMIC NEUROPATHY

      Diabetologia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 03:06:37